Sarepta Therapeutics (SRPT) Net Margin (QoQ) (2010 - 2026)

Sarepta Therapeutics (SRPT) Net Margin (QoQ) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Sarepta Therapeutics 1.66 Bn 1.25 Bn 622.04 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10,915.00
Dec 31, 2025 -1,881.00
Sep 30, 2025 -7,729.00
Jun 30, 2025 36,787.00
Mar 31, 2025 -35,976.00
Dec 31, 2024 1,692.00
Sep 30, 2024 532.00
Jun 30, 2024 -697.00
Mar 31, 2024 462.00
Dec 31, 2023 1,745.00
Sep 30, 2023 -407.00
Jun 30, 2023 21,406.00
Mar 31, 2023 -26,124.00
Dec 31, 2022 14,995.00
Sep 30, 2022 -235.00
Jun 30, 2022 -5,396.00
Mar 31, 2022 1,280.00
Dec 31, 2021 14,560.00
Sep 30, 2021 -16,441.00
Jun 30, 2021 6,422.00